<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="600">
	<fontspec id="0" size="8" family="Minion" color="#231f20"/>
	<fontspec id="1" size="8" family="Minion" color="#000000"/>
	<fontspec id="2" size="18" family="Minion" color="#231f20"/>
	<fontspec id="3" size="18" family="Minion-Black" color="#231f20"/>
	<fontspec id="4" size="12" family="Minion-Black" color="#231f20"/>
	<fontspec id="5" size="9" family="Minion" color="#231f20"/>
	<fontspec id="6" size="9" family="Minion" color="#231f20"/>
	<fontspec id="7" size="9" family="Minion" color="#000000"/>
	<fontspec id="8" size="9" family="MinionExp" color="#231f20"/>
	<fontspec id="9" size="10" family="Minion" color="#231f20"/>
	<fontspec id="10" size="10" family="Minion" color="#000000"/>
	<fontspec id="11" size="10" family="MinionExp" color="#231f20"/>
<text top="45" left="51" width="105" height="8" font="0">Hindawi Publishing Corporation</text>
<text top="54" left="51" width="93" height="8" font="0">Pain Research and Treatment</text>
<text top="64" left="51" width="104" height="8" font="0">Volume 2011, Article ID 393404,</text>
<text top="64" left="157" width="4" height="8" font="1"><a href="">6</a></text>
<text top="64" left="162" width="17" height="8" font="0">pages</text>
<text top="73" left="51" width="81" height="8" font="0">doi:10.1155/2011/393404</text>
<text top="136" left="51" width="99" height="17" font="2"><i>Review Article</i></text>
<text top="160" left="51" width="422" height="17" font="3"><b>Cancer Pain Management in Resource-Limited Settings:</b></text>
<text top="180" left="51" width="135" height="17" font="3"><b>A Practice Review</b></text>
<text top="229" left="87" width="355" height="11" font="4"><b>Elizabeth Namukwaya, Mhoira Leng, Julia Downing, and Elly Katabira</b></text>
<text top="251" left="87" width="444" height="9" font="5"><i>Department of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. BOX 7072, Kampala, Uganda</i></text>
<text top="271" left="87" width="227" height="9" font="6">Correspondence should be addressed to Elizabeth Namukwaya,</text>
<text top="271" left="315" width="92" height="9" font="7"><a href="mailto:liznam2002@yahoo.co.uk">liznam2002@yahoo.co.uk</a></text>
<text top="290" left="87" width="196" height="9" font="6">Received 1 October 2010; Accepted 14 September 2011</text>
<text top="308" left="87" width="125" height="9" font="6">Academic Editor: Howard S. Smith</text>
<text top="327" left="87" width="463" height="9" font="6">Copyright © 2011 Elizabeth Namukwaya et al. This is an open access article distributed under the Creative Commons Attribution</text>
<text top="337" left="87" width="462" height="9" font="6">License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly</text>
<text top="348" left="87" width="19" height="9" font="6">cited.</text>
<text top="366" left="87" width="224" height="9" font="6">Pain in cancer is a common and burdensome symptom with di</text>
<text top="364" left="311" width="5" height="12" font="8">ﬀ</text>
<text top="366" left="316" width="234" height="9" font="6">erent causes but in a significant number of cases it is undiagnosed</text>
<text top="377" left="87" width="462" height="9" font="6">and undertreated because of lack of skills for its assessment. Pain has significant negative impact on the patient and, therefore,</text>
<text top="387" left="87" width="463" height="9" font="6">it needs to be managed urgently and appropriately. In resource-limited settings, there are several barriers and challenges to pain</text>
<text top="398" left="87" width="463" height="9" font="6">management but even in these circumstances pain can be well managed with planned and innovative use of resources and if the</text>
<text top="408" left="87" width="338" height="9" font="6">World Health Organization public health system approach is used to ensure opioid availability.</text>
<text top="452" left="51" width="77" height="11" font="4"><b>1. Introduction</b></text>
<text top="473" left="51" width="240" height="9" font="9">Pain in cancer patients is one of the most feared and</text>
<text top="485" left="51" width="103" height="9" font="9">burdensome symptoms <a href="">[</a></text>
<text top="485" left="154" width="5" height="9" font="10"><a href="">1</a></text>
<text top="485" left="159" width="121" height="9" font="9"><a href="">] </a>and is often undertreated <a href="">[</a></text>
<text top="485" left="280" width="5" height="9" font="10"><a href="">2</a></text>
<text top="485" left="285" width="6" height="9" font="9"><a href="">].</a></text>
<text top="496" left="51" width="240" height="9" font="9">In a recent systematic review, the prevalence of pain was</text>
<text top="507" left="51" width="240" height="9" font="9">found to be 64% in patients with advanced and metastatic</text>
<text top="519" left="51" width="240" height="9" font="9">disease, 59% in those on anticancer treatment, and 33%</text>
<text top="530" left="51" width="170" height="9" font="9">in those who had been cured of cancer <a href="">[</a></text>
<text top="530" left="221" width="5" height="9" font="10"><a href="">1</a></text>
<text top="530" left="226" width="65" height="9" font="9"><a href="">]. </a>In Africa, the</text>
<text top="542" left="51" width="240" height="9" font="9">prevalence of cancer pain ranges from 35.7% to 87.5% with</text>
<text top="553" left="51" width="240" height="9" font="9">the prevalence being more than 70% in most of the studies</text>
<text top="564" left="51" width="4" height="9" font="9"><a href="">[</a></text>
<text top="564" left="54" width="5" height="9" font="10"><a href="">3</a></text>
<text top="564" left="59" width="5" height="9" font="9"><a href="">–</a></text>
<text top="564" left="64" width="5" height="9" font="10"><a href="">9</a></text>
<text top="564" left="69" width="222" height="9" font="9"><a href="">]. </a>This high prevalence may be attributed to the limited</text>
<text top="576" left="51" width="240" height="9" font="9">treatment options for cancer, individuals presenting late,</text>
<text top="587" left="51" width="240" height="9" font="9">and comorbidity along with limited choice and availability</text>
<text top="598" left="51" width="240" height="9" font="9">of analgesics. In developed countries, evidence shows that</text>
<text top="610" left="51" width="240" height="9" font="9">56–85% of cases of pain in cancer are tumor related, 5–</text>
<text top="621" left="51" width="240" height="9" font="9">62% of cases are related to cancer treatment, and 3–22%</text>
<text top="633" left="51" width="183" height="9" font="9">are unrelated to the cancer or its treatment <a href="">[</a></text>
<text top="633" left="234" width="10" height="9" font="10"><a href="">10</a></text>
<text top="633" left="243" width="2" height="9" font="9">,</text>
<text top="633" left="249" width="10" height="9" font="10"><a href="">11</a></text>
<text top="633" left="258" width="33" height="9" font="9">]. There</text>
<text top="644" left="51" width="240" height="9" font="9">is limited published data from resource-limited settings on</text>
<text top="655" left="51" width="240" height="9" font="9">the causes of pain in cancer patients; most data is limited</text>
<text top="667" left="51" width="240" height="9" font="9">to prevalence of pain in these patients and in most cases</text>
<text top="678" left="51" width="188" height="9" font="9">it is assumed that pain is due to the tumor <a href="">[</a></text>
<text top="678" left="239" width="5" height="9" font="10"><a href="">3</a></text>
<text top="678" left="244" width="5" height="9" font="9"><a href="">–</a></text>
<text top="678" left="249" width="5" height="9" font="10"><a href="">9</a></text>
<text top="678" left="253" width="2" height="9" font="9">,</text>
<text top="678" left="260" width="10" height="9" font="10"><a href="">12</a></text>
<text top="678" left="269" width="2" height="9" font="9">,</text>
<text top="678" left="275" width="10" height="9" font="10"><a href="">13</a></text>
<text top="678" left="285" width="6" height="9" font="9"><a href="">].</a></text>
<text top="689" left="51" width="240" height="9" font="9">This is probably because in resource-limited countries there</text>
<text top="701" left="51" width="240" height="9" font="9">are limited treatment options for most cancers, and patients</text>
<text top="712" left="51" width="240" height="9" font="9">present late with advanced malignancy, and, therefore, it is</text>
<text top="723" left="51" width="240" height="9" font="9">likely that more of the pain will be due to the tumor and</text>
<text top="735" left="51" width="240" height="9" font="9">less due to treatment as compared to developed countries.</text>
<text top="453" left="309" width="240" height="9" font="9">Pain unrelated to the cancer or its treatment is of significant</text>
<text top="465" left="309" width="240" height="9" font="9">importance in resource-limited settings, where the burden</text>
<text top="476" left="309" width="240" height="9" font="9">of HIV/AIDS is high and, therefore, patients might have</text>
<text top="488" left="309" width="240" height="9" font="9">HIV-associated malignancies and their pain may be due</text>
<text top="499" left="309" width="240" height="9" font="9">to the HIV or associated opportunistic infections and/or</text>
<text top="510" left="309" width="97" height="9" font="9">antiretroviral treatment.</text>
<text top="522" left="324" width="225" height="9" font="9">Therefore, a good pain assessment is important to iden-</text>
<text top="533" left="309" width="158" height="9" font="9">tify the cause and be able to manage it e</text>
<text top="531" left="466" width="6" height="13" font="11">ﬀ</text>
<text top="533" left="472" width="31" height="9" font="9">ectively.</text>
<text top="566" left="309" width="219" height="11" font="4"><b>2. The Impact of Cancer Pain on the Patient</b></text>
<text top="587" left="309" width="240" height="9" font="9">Chronic cancer pain has a significant impact on the patients</text>
<text top="598" left="309" width="240" height="9" font="9">and their family. Thirty-six percent of patients on anticancer</text>
<text top="610" left="309" width="240" height="9" font="9">treatment have reported their pain to be of moderate-to-</text>
<text top="621" left="309" width="240" height="9" font="9">severe intensity and 45% of patients with advanced, terminal,</text>
<text top="633" left="309" width="240" height="9" font="9">and metastatic disease reported pain of moderate-to-severe</text>
<text top="644" left="309" width="240" height="9" font="9">intensity in a systematic review done on studies carried</text>
<text top="655" left="309" width="148" height="9" font="9">out mainly in developed countries <a href="">[</a></text>
<text top="655" left="457" width="5" height="9" font="10"><a href="">1</a></text>
<text top="655" left="461" width="87" height="9" font="9">]. In resource-limited</text>
<text top="667" left="309" width="240" height="9" font="9">settings, pain has been found to be of moderate-to-severe</text>
<text top="678" left="309" width="240" height="9" font="9">intensity in 30% to 70% of cases. In the majority of the</text>
<text top="689" left="309" width="240" height="9" font="9">studies, moderate-to-severe pain was registered in more than</text>
<text top="701" left="309" width="83" height="9" font="9">50% of the patients <a href="">[</a></text>
<text top="701" left="392" width="5" height="9" font="10"><a href="">3</a></text>
<text top="701" left="396" width="2" height="9" font="9">,</text>
<text top="701" left="401" width="10" height="9" font="10"><a href="">13</a></text>
<text top="701" left="411" width="5" height="9" font="9"><a href="">–</a></text>
<text top="701" left="416" width="10" height="9" font="10"><a href="">16</a></text>
<text top="701" left="425" width="6" height="9" font="9">].</text>
<text top="712" left="324" width="225" height="9" font="9">An individual’s perception of pain may be influenced</text>
<text top="723" left="309" width="240" height="9" font="9">by many issues including psychological, social, cultural,</text>
<text top="735" left="309" width="101" height="9" font="9">and spiritual factors. Ko</text>
<text top="732" left="410" width="6" height="13" font="11">ﬀ</text>
<text top="735" left="415" width="134" height="9" font="9">man et al. explored the cultural</text>
</page>
</pdf2xml>
